Clinical Trials
Oxford leads first trial investigating dosing with alternating vaccines
The University of Oxford is to lead the first trial to explore alternating different COVID-19 vaccines, to explore the potential for flexibility in delivery and look for clues as to how to increase the breadth of protection against new...
News
Metrics Contract Services Appoints New VP of Business Development
Metrics Contract Services, a full-service contract development and manufacturing organization (CDMO) in novel oral solid dose products, has appointed Britton Jimenez as Vice President of Business Development.
Britton is responsible for marketing and sales in an executive leadership capacity to...
Drug Research
Abzena selected to develop and manufacture antibody cocktail for Immunome’s COVID-19 Antibody Based Treatment
Immunome, Inc., a biopharmaceutical company utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics, and Abzena, a partner research organization for integrated discovery to cGMP manufacturing solutions for biologics, today announced that Abzena...
News
WuXi STA to Purchase Bristol Myers Squibb Manufacturing Facility in Couvet, Switzerland
Bristol Myers Squibb and WuXi STA – a subsidiary of WuXi AppTec – announced that WuXi STA has agreed to purchase Bristol Myers Squibb’s manufacturing facility in Couvet, Switzerland. The Couvet site will be the first facility in Europe...
News
eClinical Solutions Launches elluminate Clinical Trial Management System for Faster Drug Development
eClinical Solutions LLC, a global provider of cloud-based enterprise software and software-driven clinical data services, announced the launch of the elluminate® Clinical Trial Management System (CTMS). Built on the elluminate platform, which accelerates digitization and reduces clinical data review...
Clinical Trials
Ampio Announces Early Positive Data in Phase 1 Trial of Inhaled Ampion in COVID-19 Respiratory Distress
Ampio Pharmaceuticals, Inc., a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, announced early positive data from its ongoing U.S. Phase I controlled, observer-blinded clinical trial of inhaled Ampion versus standard of care for...
News
Novartis to support Pfizer-BioNTechs Covid-19 vaccine production
Novartis has signed an initial agreement to support the production of Pfizer and BioNTech’s Covid-19 vaccine by leveraging its manufacturing capacity and capabilities to fight the Covid-19 pandemic.
Novartis has signed an initial agreement to support the production of Pfizer...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















